Status:
COMPLETED
Predictors of Recurrence for High Risk Endometrial Cancer Patients
Lead Sponsor:
Far Eastern Memorial Hospital
Conditions:
High-risk Endometrial Cancer
Eligibility:
FEMALE
20+ years
Brief Summary
This study will analyze whether there is any difference in recurrence and survival rates among the patients who received different adjuvant therapies.
Detailed Description
The incidence of endometrial cancer is gradually increasing nowaday. The postoperative treatment of high-risk endometrial cancer is also inconsistent. Besides, the recurrence of high-risk endometrial ...
Eligibility Criteria
Inclusion
- All patients with high risk stage I endometrial cancer and all patients with stage II and stage III endometrial cancer and who underwent therapy in Far Eastern Memorial Hospital from 2009/01/01\~2019/09/17.
Exclusion
- Patients with stage I endometrial cancer do not have high risk factors.
Key Trial Info
Start Date :
April 25 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
November 25 2020
Estimated Enrollment :
92 Patients enrolled
Trial Details
Trial ID
NCT04412902
Start Date
April 25 2020
End Date
November 25 2020
Last Update
December 9 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Department of Obstetrics and Gynecology, Far-Eastern Memorial Hospital
Banqiao District, New Taipei, Taiwan, 22050